FI101128B - Menetelmä infektioita aiheuttamattoman veriplasman valmistamiseksi - Google Patents

Menetelmä infektioita aiheuttamattoman veriplasman valmistamiseksi Download PDF

Info

Publication number
FI101128B
FI101128B FI915301A FI915301A FI101128B FI 101128 B FI101128 B FI 101128B FI 915301 A FI915301 A FI 915301A FI 915301 A FI915301 A FI 915301A FI 101128 B FI101128 B FI 101128B
Authority
FI
Finland
Prior art keywords
plasma
process according
blood plasma
phase extraction
tnbp
Prior art date
Application number
FI915301A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI915301A0 (fi
Inventor
Dieter Wolter
Horst Schwinn
Original Assignee
New York Blood Ct Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6402597&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI101128(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by New York Blood Ct Inc filed Critical New York Blood Ct Inc
Publication of FI915301A0 publication Critical patent/FI915301A0/fi
Application granted granted Critical
Publication of FI101128B publication Critical patent/FI101128B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI915301A 1990-03-20 1991-11-11 Menetelmä infektioita aiheuttamattoman veriplasman valmistamiseksi FI101128B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4008852 1990-03-20
DE4008852A DE4008852A1 (de) 1990-03-20 1990-03-20 Verfahren zur herstellung von nicht-infektioesem blutplasma
PCT/EP1991/000503 WO1991014439A1 (de) 1990-03-20 1991-03-16 Verfahren zur herstellung von nicht-infektiösem blutplasma
EP9100503 1991-03-16

Publications (2)

Publication Number Publication Date
FI915301A0 FI915301A0 (fi) 1991-11-11
FI101128B true FI101128B (fi) 1998-04-30

Family

ID=6402597

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915301A FI101128B (fi) 1990-03-20 1991-11-11 Menetelmä infektioita aiheuttamattoman veriplasman valmistamiseksi

Country Status (8)

Country Link
EP (1) EP0472708B1 (https=)
JP (1) JP2708632B2 (https=)
AT (1) ATE110272T1 (https=)
DE (3) DE4008852A1 (https=)
DK (1) DK0472708T3 (https=)
ES (1) ES2059129T3 (https=)
FI (1) FI101128B (https=)
WO (1) WO1991014439A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018665A1 (en) * 1994-01-10 1995-07-13 Hemasure, Inc. Device and process for removing leukocytes and viral inactivating agents from blood
US5639376A (en) * 1994-01-10 1997-06-17 Hemasure, Inc. Process for simultaneously removing leukocytes and methylene blue from plasma
US6136865A (en) * 1995-05-20 2000-10-24 Octapharma Ag Method for reduction of the infectiousness of potentially infectious material
DE19729778A1 (de) * 1997-07-11 1999-01-21 Blutspendedienst Der Drk Lande Verfahren zur Herstellung von virusinaktivierten biologischen Flüssigkeiten
EP0896824A1 (en) † 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
JP2010209109A (ja) * 2001-06-25 2010-09-24 Regents Of The Univ Of Michigan 抗微生物ナノエマルジョンの組成物および方法
CN1302009C (zh) * 2005-09-05 2007-02-28 武汉海特生物制药股份有限公司 用有机溶剂病毒灭活法制备鼠神经生长因子的工艺
WO2008137747A1 (en) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
US9974844B2 (en) 2008-11-17 2018-05-22 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
DE3173208D1 (en) * 1980-10-06 1986-01-23 Edward Shanbrom Method of reducing undesirable activities of biological and pharmaceutical products
US4591505A (en) * 1982-04-14 1986-05-27 New York Blood Center, Inc. Process for inactivating hepatitis B virus
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
ATE85221T1 (de) * 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.

Also Published As

Publication number Publication date
ATE110272T1 (de) 1994-09-15
FI915301A0 (fi) 1991-11-11
DE4008852C2 (https=) 1992-06-17
DE4008852A1 (de) 1991-09-26
DE4021542C2 (de) 1995-08-17
JPH04506668A (ja) 1992-11-19
DE59102623D1 (de) 1994-09-29
WO1991014439A1 (de) 1991-10-03
DK0472708T3 (da) 1994-09-19
EP0472708B1 (de) 1994-08-24
EP0472708A1 (de) 1992-03-04
JP2708632B2 (ja) 1998-02-04
ES2059129T3 (es) 1994-11-01
DE4021542A1 (de) 1992-01-09

Similar Documents

Publication Publication Date Title
EP0239859B1 (en) Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
FI101128B (fi) Menetelmä infektioita aiheuttamattoman veriplasman valmistamiseksi
AU621148B2 (en) Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
JP4808864B2 (ja) ウイルスの不活化方法
JPH01294629A (ja) ハロゲン化炭化水素により不安定生物混合物からプロセス化学薬品を抽出する方法
EA003182B1 (ru) Универсальная плазма крови
TW201207113A (en) Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof
TW200942247A (en) Virally-inactivated biological fluid, virally inactivating method thereof and use of the method
US5696236A (en) Method for the removal of viruses from protein solutions
US10357512B2 (en) Method for preparing universal plasma
RU2040260C1 (ru) Способ получения неинфицированной плазмы крови
CN101005859A (zh) 灭病毒生物液体的制备方法
US6007979A (en) Method for reduction of the infectiousness of potentially infectious material
SK279910B6 (sk) Spôsob výroby krvnej plazmy bez infekčných zárodko
PL167173B1 (pl) Sposób wytwarzania niezakażającego osocza krwi
RU2140287C1 (ru) Способ получения альбумина
Geipert et al. Properties of granules that contain kallikrein and renin
Nazari et al. Virus reduction of human plasma-derived biological medicines
US5912328A (en) Method for the removal of viruses from protein solutions
CS277138B6 (cs) Způsob průmyslové výroby přenosového faktoru
RO110678B1 (ro) Procedeu pentru prepararea plasmei sanguine, neinfecțioase
Sitalakshmi et al. The Past and Present of Transfusion Medicine
EP0338620A1 (en) Recovery of hepatitis B surface antigen
MXPA00001259A (en) A universally applicable blood plasma

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: THE NEW YORK BLOOD CENTER, INC.